US Patent 11286265 Macrocyclic compounds for treating disease
Patent 11286265 was granted and assigned to Turning Point Therapeutics on March, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
May 5, 2020
0
Date of Patent
March 29, 2022
0
Patent Applicant
Patent Application Number
16866983
0
Patent Inventor Names
Dayong Zhai
0
Wei Deng
0
Jingrong J. Cui
0
Jeffrey Whitten
0
Jane Ung
0
Han Zhang
0
Evan W. Rogers
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11286265 Macrocyclic compounds for treating disease
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
